Structural basis for engagement by complement factor H of C3b on a self surface

Nature Structural and Molecular Biology

Volumn 18, Issue 4, 2011, Pages 463-471

  Morgan, Hugh P ^a   Schmidt, Christoph Q ^b   Guariento, Mara ^b   Blaum, Bäbel S ^b,e   Gillespie, Dominic ^a   Herbert, Andrew P ^b,f   Kavanagh, David ^c   Mertens, Haydyn D T ^d   Svergun, Dmitri I ^d   Johansson, Conny M ^b   Uhrín, Dušan ^b   Barlow, Paul N ^b   Hannan, Jonathan P ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

^d EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

^e UNIVERSITY OF TÜBINGEN   (Germany)

^f UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3B; COMPLEMENT FACTOR H; GLYCOSAMINOGLYCAN;

ARTICLE; CONTROLLED STUDY; CRYSTAL STRUCTURE; HUMAN; MUTAGENESIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; X RAY CRYSTALLOGRAPHY;

BINDING SITES; COMPLEMENT C3B; COMPLEMENT FACTOR H; CRYSTALLOGRAPHY, X-RAY; MODELS, MOLECULAR; MUTAGENESIS; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PROTEIN CONFORMATION;

EID: 79953772478     PISSN: 15459993     EISSN: 15459985     Source Type: Journal    
DOI: 10.1038/nsmb.2018     Document Type: Article

References (60)

1. Ricklin, D., Hajishengallis, G., Yang, K. & Lambris, J.D. Complement: a key system for immune surveillance and homeostasis. Nat Immunol. 11, 785-797 (2010).
2. de Córdoba, S.R. & de Jorge, E.G. Translational mini-review series on complement factor H: genetics and disease associations of human complement factor H. Clin. Exp. Immunol. 151, 1-13 (2008). (Pubitemid 350230999)
3. Janssen, B.J., Christodoulidou, A., McCarthy, A., Lambris, J.D. & Gros, P. Structure of C3b reveals conformational changes that underlie complement activity. Nature 444, 213-216 (2006). (Pubitemid 44722062)
4. Pangburn, M.K., Schreiber, R.D. & Muller-Eberhard, H.J. Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solution. J. Exp. Med. 146, 257-270 (1977). (Pubitemid 8139507)
5. Weiler, J.M., Daha, M.R., Austen, K.F. & Fearon, D.T. Control of the amplifcation convertase of complement by the plasma protein beta1H. Proc Natl. Acad. Sci. USA 73, 3268-3272 (1976).
6. Whaley, K. & Ruddy, S. Modulation of the alternative complement pathways by beta 1 H globulin. J. Exp. Med. 144, 1147-1163 (1976).
7. Ripoche, J. et al. Partial characterization of human complement factor H by protein and cDNA sequencing: homology with other complement and non-complement proteins. Biosci. Rep. 6, 65-72 (1986). (Pubitemid 16102528)
8. Meri, S. & Pangburn, M.K. Regulation of alternative pathway complement activation by glycosaminoglycans: specifcity of the polyanion binding site on factor H. Biochem. Biophys. Res. Commun. 198, 52-59 (1994). (Pubitemid 24172719)
9. Pangburn, M.K. Host recognition and target differentiation by factor H, a regulator of the alternative pathway of complement. Immunopharmacology 49, 149-157 (2000). (Pubitemid 30445226)
10. Gordon, D.L., Kaufman, R.M., Blackmore, T.K., Kwong, J. & Lublin, D.M. Identifcation of complement regulatory domains in human factor H. J. Immunol. 155, 348-356 (1995).
11. Pangburn, M.K. Cutting edge: localization of the host recognition functions of complement factor H at the carboxyl-terminal: implications for hemolytic uremic syndrome. J. Immunol. 169, 4702-4706 (2002). (Pubitemid 35217129)
12. Schmidt, C.Q. et al. A new map of glycosaminoglycan and C3b binding sites on factor H. J. Immunol. 181, 2610-2619 (2008).
13. Sharma, A.K. & Pangburn, M.K. Identifcation of three physically and functionally distinct binding sites for C3b in human complement factor H by deletion mutagenesis. Proc Natl. Acad. Sci. USA 93, 10996-11001 (1996). (Pubitemid 26333106)
14. Wu, J. et al. Structure of complement fragment C3b-factor H and implications for host protection by complement regulators. Nat Immunol. 10, 728-733 (2009).
15. Buddles, M.R., Donne, R.L., Richards, A., Goodship, J. & Goodship, T.H. Complement factor H gene mutation associated with autosomal recessive atypical hemolytic uremic syndrome. Am. J. Hum. Genet. 66, 1721-1722 (2000). (Pubitemid 30463094)
16. Herbert, A.P., Uhrin, D., Lyon, M., Pangburn, M.K. & Barlow, P.N. Disease-associated sequence variations congregate in a polyanion recognition patch on human factor H revealed in three-dimensional structure. J. Biol. Chem. 281, 16512-16520 (2006).
17. Pérez-Caballero, D. et al. Clustering of missense mutations in the C-terminal region of factor H in atypical hemolytic uremic syndrome. Am. J. Hum. Genet. 68, 478-484 (2001). (Pubitemid 32147816)
18. Ferreira, V.P., Herbert, A.P., Hocking, H.G., Barlow, P.N. & Pangburn, M.K. Critical role of the C-terminal domains of factor H in regulating complement activation at cell surfaces. J. Immunol. 177, 6308-6316 (2006). (Pubitemid 44628849)
19. Jokiranta, T.S. et al. Binding of complement factor H to endothelial cells is mediated by the carboxy-terminal glycosaminoglycan binding site. Am. J. Pathol. 167, 1173-1181 (2005). (Pubitemid 41416267)
20. Blackmore, T.K. et al. Identifcation of the second heparin-binding domain in human complement factor H. J. Immunol. 160, 3342-3348 (1998). (Pubitemid 28164726)
21. Blackmore, T.K., Sadlon, T.A., Ward, H.M., Lublin, D.M. & Gordon, D.L. Identifcation of a heparin binding domain in the seventh short consensus repeat of complement factor H. J. Immunol. 157, 5422-5427 (1996). (Pubitemid 126448961)
22. Hageman, G.S. et al. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl. Acad. Sci. USA 102, 7227-7232 (2005). (Pubitemid 40696361)
23. Klein, R.J. et al. Complement factor H polymorphism in age-related macular degeneration. Science 308, 385-389 (2005). (Pubitemid 40530070)
24. Kuehn, B.M. Gene discovery provides clues to cause of age-related macular degeneration. J. Am. Med. Assoc 293, 1841-1845 (2005).
25. Zareparsi, S. et al. Strong association of the Y402H variant in complement factor H at 1q32 with susceptibility to age-related macular degeneration. Am. J. Hum. Genet. 77, 149-153 (2005). (Pubitemid 40848046)
26. Wiesmann, C et al. Structure of C3b in complex with CRIg gives insights into regulation of complement activation. Nature 444, 217-220 (2006). (Pubitemid 44722063)
27. Lian, L.Y., Barsukov, I.L., Sutcliffe, M.J., Sze, K.H. & Roberts, G.C. Protein-ligand interactions: exchange processes and determination of ligand conformation and protein-ligand contacts. Methods Enzymol. 239, 657-700 (1994).
28. Matsuo, H. et al. Identifcation by NMR spectroscopy of residues at contact surfaces in large, slowly exchanging macromolecular complexes. J. Am. Chem. Soc. 121, 9903-9904 (1999). (Pubitemid 29517442)
29. Daughdrill, G.W. et al. Chemical shift changes provide evidence for overlapping single-stranded DNA-and XPA-binding sites on the 70 kDa subunit of human replication protein A. Nucleic Acids Res. 31, 4176-4183 (2003). (Pubitemid 37442297)
30. McAlister, M.S.B. et al. NMR analysis of interacting soluble forms of the cell-cell recognition molecules CD2 and CD48. Biochemistry 35, 5982-5991 (1996). (Pubitemid 26147569)
31. Ferreira, V.P. et al. The binding of factor H to a complex of physiological polyanions and C3b on cells is impaired in atypical hemolytic uremic syndrome. J. Immunol. 182, 7009-7018 (2009).
32. Lehtinen, M.J., Rops, A.L., Isenman, D.E., van der Vlag, J. & Jokiranta, T.S. Mutations of factor H impair regulation of surface-bound C3b by three mechanisms in atypical hemolytic uremic syndrome. J. Biol. Chem. 284, 15650-15658 (2009).
33. Morikis, D. & Lambris, J.D. The electrostatic nature of C3d-complement receptor 2 association. J. Immunol. 172, 7537-7547 (2004). (Pubitemid 38747617)
34. Ricklin, D., Ricklin-Lichtsteiner, S.K., Markiewski, M.M., Geisbrecht, B.V. & Lambris, J.D. Cutting edge: members of the Staphylococcus aureus extracellular fbrinogen-binding protein family inhibit the interaction of C3d with complement receptor 2. J. Immunol. 181, 7463-7467 (2008).
35. Bhattacharjee, A., Lehtinen, M.J., Kajander, T., Goldman, A. & Jokiranta, T.S. Both domain 19 and domain 20 of factor H are involved in binding to complement C3b and C3d. Mol. Immunol. 47, 1686-1691 (2010).
36. Prosser, B.E. et al. Structural basis for complement factor H linked age-related macular degeneration. J. Exp. Med. 204, 2277-2283 (2007). (Pubitemid 47529315)
37. Schmidt, C.Q. et al. The central portion of factor H (modules 10-15) is compact and contains a structurally deviant CCP module. J. Mol. Biol. 395, 105-122 (2010).
38. Barlow, P.N. et al. Solution structure of a pair of complement modules by nuclear magnetic resonance. J. Mol. Biol. 232, 268-284 (1993). (Pubitemid 23245413)
39. Barlow, P.N. et al. Solution structure of the ffth repeat of factor H: a second example of the complement control protein module. Biochemistry 31, 3626-3634 (1992).
40. Szakonyi, G. et al. Structure of complement receptor 2 in complex with its C3d ligand. Science 292, 1725-1728 (2001). (Pubitemid 32506247)
41. Hammel, M. et al. A structural basis for complement inhibition by Staphylococcus aureus. Nat Immunol. 8, 430-437 (2007). (Pubitemid 46745418)
42. Chen, H. et al. Allosteric inhibition of complement function by a staphylococcal immune evasion protein. Proc Natl. Acad. Sci. USA 107, 17621-17626 (2010).
43. Jokiranta, T.S. et al. Structure of complement factor H carboxyl-terminus reveals molecular basis of atypical haemolytic uremic syndrome. EMBO J. 25, 1784-1794 (2006).
44. Saunders, R.E. et al. The interactive Factor H-atypical hemolytic uremic syndrome mutation database and website: update and integration of membrane cofactor protein and Factor I mutations with structural models. Hum. Mutat 28, 222-234 (2007).
45. Miller, E.C., Roumenina, L., Fremeaux-Bacchi, V. & Atkinson, J.P. Functional characterization of mutations in complement C3 that predispose to aHUS. Mol. Immunol. 47, 2291 (2010).
46. Frémeaux-Bacchi, V. et al. Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome. Blood 112, 4948-4952 (2008).
47. Aslam, M. & Perkins, S.J. Folded-back solution structure of monomeric factor H of human complement by synchrotron X-ray and neutron scattering, analytical ultracentrifugation and constrained molecular modelling. J. Mol. Biol. 309, 1117-1138 (2001). (Pubitemid 32623312)
48. Fernando, A.N. et al. Associative and structural properties of the region of complement factor H encompassing the Tyr402His disease-related polymorphism and its interactions with heparin. J. Mol. Biol. 368, 564-581 (2007). (Pubitemid 46483491)
49. Oppermann, M. et al. The C-terminus of complement regulator Factor H mediates target recognition: evidence for a compact conformation of the native protein. Clin. Exp. Immunol. 144, 342-352 (2006).
50. Okemefuna, A.I. et al. The regulatory SCR-1/5 and cell surface-binding SCR-16/20 fragments of factor H reveal partially folded-back solution structures and different self-associative properties. J. Mol. Biol. 375, 80-101 (2008). (Pubitemid 350161888)
51. Baker, N.A., Sept, D., Joseph, S., Holst, M.J. & McCammon, J.A. Electrostatics of nanosystems: application to microtubules and the ribosome. Proc Natl. Acad. Sci. USA 98, 10037-10041 (2001). (Pubitemid 32802969)
52. Young, K.A., Chen, X.S., Holers, V.M. & Hannan, J.P. Isolating the Epstein-Barr virus gp350/220 binding site on complement receptor type 2 (CR2/CD21). J. Biol. Chem. 282, 36614-36625 (2007).
53. Shaw, C.D. et al. Delineation of the complement receptor type 2-C3d complex by site-directed mutagenesis and molecular docking. J. Mol. Biol. 404, 697-710 (2010).
54. Leslie, A.G.W. Recent changes to the MOSFLM package for processing flm and image plate data. Joint CCP4 ESF-EAMCB Newslett. Protein Crystallogr. 26, (1992).
55. Evans, P. Scaling and assessment of data quality. Acta Crystallogr. D Biol. Crystallogr. 62, 72-82 (2006).
56. McCoy, A.J. et al. Phaser crystallographic software. J. Appl. Cryst. 40, 658-674 (2007). (Pubitemid 47080256)
57. Nagar, B., Jones, R.G., Diefenbach, R.J., Isenman, D.E. & Rini, J.M. X-ray crystal structure of C3d: a C3 fragment and ligand for complement receptor 2. Science 280, 1277-1281 (1998). (Pubitemid 128667610)
58. Murshudov, G.N., Vagin, A.A. & Dodson, E.J. Refnement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr. D Biol. Crystallogr. 53, 240-255 (1997). (Pubitemid 27235885)
59. Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60, 2126-2132 (2004).
60. Davis, I.W. et al. MolProbity: all-atom contacts and structure validation for proteins and nucleic acids. Nucleic Acids Res. 35, W375-W383 (2007).